Cargando…

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs

This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain.

Detalles Bibliográficos
Autores principales:	Mattingly, T. Joseph, Ben-Umeh, Kenechukwu C., Bai, Ge, Anderson, Gerard F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589804/ https://www.ncbi.nlm.nih.gov/pubmed/37862035 http://dx.doi.org/10.1001/jamahealthforum.2023.3660

Ejemplares similares

Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Hospital Prices in Medicaid Managed Care
por: Marr, Jeffrey, et al.
Publicado: (2023)

Price dispersion of generic medications
por: Bernstein, John J. J., et al.
Publicado: (2019)

Pharmacy’s Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging
por: Mattingly, T. Joseph, et al.
Publicado: (2020)

Upstream solutions for price-gouging on critical generic medicines
por: Houston, Adam R., et al.
Publicado: (2016)

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?
por: Trujillo, Antonio J., et al.
Publicado: (2022)

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018)

The benefits of more government interference in prescription drug pricing
por: Houser, Ryan S.
Publicado: (2022)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Comparison of US Hospital Cash Prices and Commercial Negotiated Prices for 70 Services
por: Jiang, John (Xuefeng), et al.
Publicado: (2021)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
por: Narendrula, Aparna, et al.
Publicado: (2023)

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
por: Mattingly, T. Joseph, et al.
Publicado: (2018)

Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020
por: Jenei, Kristina, et al.
Publicado: (2023)

Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
por: Gallant, Joel
Publicado: (2015)

An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023)

Monthly Prices of Substances Used in Pharmacy
Publicado: (1814)

The international drug price indicator guide: An objective source of information about medicine prices
por: Shankar, Pathiyil Ravi
Publicado: (2014)

Variation in Prices of Cardiovascular Drugs in Public and Private Pharmacies in Nepal
por: Mishra, Shiva Raj, et al.
Publicado: (2015)

Cross-sectional Study on the Impact of Discount Pricing and Price Competition on Community Pharmacy Practice
por: Mathews, Allan, et al.
Publicado: (2020)

The Short-Term Impact of Ontario's Generic Pricing Reforms
por: Law, Michael R., et al.
Publicado: (2011)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
por: Zhang, Wei, et al.
Publicado: (2020)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017)

Is greater generic competition also linked to lower drug prices in South Korea?
por: Son, Kyung-Bok
Publicado: (2020)

Capitation pricing: Adjusting for prior utilization and physician discretion
por: Anderson, Gerard F., et al.
Publicado: (1986)

Comparison of Commercial Negotiated Price and Cash Price Between Physician-Owned Hospitals and Other Hospitals in the Same Hospital Referral Region
por: Wang, Yang, et al.
Publicado: (2023)

Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism
por: Zin, Che Suraya, et al.
Publicado: (2020)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016)

The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs
por: Chen, Chi-Liang, et al.
Publicado: (2008)

Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022
por: Nikpay, Sayeh, et al.
Publicado: (2023)

Online Drug Pricing Tools Deserve More Attention
por: Grunewald, Alexander
Publicado: (2011)

Excess Medicaid Payments and the Stock Prices of Drug Companies
por: Grant, William C.
Publicado: (2012)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

Commercial COVID-19 PCR Test Price in US Hospitals
por: Jiang, John Xuefeng, et al.
Publicado: (2023)

Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
por: Meiners, Constance, et al.
Publicado: (2011)

Ontario’s plunging price-caps on generics: deeper dives may drown some drugs
por: Anis, Aslam, et al.
Publicado: (2011)

A comparison of generic drug prices in seven European countries: a methodological analysis
por: Wouters, Olivier J., et al.
Publicado: (2017)

Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines
por: Martínez-Sesmero, José M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja14lru5d2ajjd1aseno1808e9